{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:00:38Z","timestamp":1772809238576,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Ministry of Education and Science | Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/98536\/2013"],"award-info":[{"award-number":["SFRH\/BD\/98536\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Ministry of Education and Science | Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/124155\/2016"],"award-info":[{"award-number":["SFRH\/BD\/124155\/2016"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Ministry of Education and Science | Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/114803\/2016"],"award-info":[{"award-number":["SFRH\/BPD\/114803\/2016"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s41397-018-0056-y","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T17:02:52Z","timestamp":1538586172000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacogenomics in epithelial ovarian cancer first-line treatment outcome: validation of GWAS-associated NRG3 rs1649942 and BRE rs7572644 variants in an independent cohort"],"prefix":"10.1038","volume":"19","author":[{"given":"Ricardo","family":"Pinto","sequence":"first","affiliation":[]},{"given":"Joana","family":"Assis","sequence":"additional","affiliation":[]},{"given":"Augusto","family":"Nogueira","sequence":"additional","affiliation":[]},{"given":"Carina","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Coelho","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Brand\u00e3o","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Dias","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Deolinda","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"key":"56_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer . 2015;136:E359\u2013386.","journal-title":"Int J Cancer"},{"key":"56_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00228-016-2015-3","volume":"72","author":"D Pereira","year":"2016","unstructured":"Pereira D, Assis J, Gomes M, Nogueira A, Medeiros R. Improvement of a predictive model in ovarian cancer patients submitted to platinum-based chemotherapy: implications of a GST activity profile. Eur J Clin Pharmacol. 2016;72:545\u201353.","journal-title":"Eur J Clin Pharmacol"},{"key":"56_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ygyno.2011.10.034","volume":"124","author":"I Diaz-Padilla","year":"2012","unstructured":"Diaz-Padilla I, Amir E, Marsh S, Liu G, Mackay H. Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: a systematic review. Gynecol Oncol. 2012;124:354\u201365.","journal-title":"Gynecol Oncol"},{"key":"56_CR4","first-page":"401","volume":"14","author":"E Caiola","year":"2014","unstructured":"Caiola E, Broggini M, Marabese M. Genetic markers for prediction of treatment outcomes in ovarian cancer. Pharm J. 2014;14:401\u201310.","journal-title":"Pharm J"},{"key":"56_CR5","first-page":"552","volume":"6","author":"J Assis","year":"2013","unstructured":"Assis J, Pereira D, Gomes M, Marques D, Marques I, Nogueira A, et al. Influence of CYP3A4 genotypes in the outcome of serous ovarian cancer patients treated with first-line chemotherapy: implication of a CYP3A4 activity profile. Int J Clin Exp Med. 2013;6:552\u201361.","journal-title":"Int J Clin Exp Med"},{"key":"56_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1086\/519850","volume":"81","author":"RS Huang","year":"2007","unstructured":"Huang RS, Duan S, Shukla SJ, Kistner EO, Clark TA, Chen TX, et al. Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am J Hum Genet. 2007;81:427\u201337.","journal-title":"Am J Hum Genet"},{"key":"56_CR7","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2217\/pgs-2017-0108","volume":"18","author":"R Pinto","year":"2017","unstructured":"Pinto R, Assis J, Nogueira A, Pereira C, Pereira D, Medeiros R. Rethinking ovarian cancer genomics: where genome-wide association studies stand? Pharmacogenomics. 2017;18:1611\u201325.","journal-title":"Pharmacogenomics"},{"key":"56_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3802\/jgo.2015.26.2.87","volume":"26","author":"J Prat","year":"2015","unstructured":"Prat J, Oncology FCoG. FIGO\u2019s staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication. J Gynecol Oncol. 2015;26:87\u201389.","journal-title":"J Gynecol Oncol"},{"key":"56_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","volume":"21","author":"GJ Rustin","year":"2011","unstructured":"Rustin GJ, Vergote I, Eisenhauer E, Pujade-Lauraine E, Quinn M, Thigpen T, et al. Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). Int J Gynecol Cancer. 2011;21:419\u201323.","journal-title":"Int J Gynecol Cancer"},{"issue":"D1","key":"56_CR10","doi-asserted-by":"publisher","first-page":"D896","DOI":"10.1093\/nar\/gkw1133","volume":"45","author":"J MacArthur","year":"2017","unstructured":"MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res. 2017;45(D1):D896\u2013901.","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issu","key":"56_CR11","doi-asserted-by":"publisher","first-page":"W201","DOI":"10.1093\/nar\/gkq513","volume":"38","author":"SF Saccone","year":"2010","unstructured":"Saccone SF, Bolze R, Thomas P, Quan J, Mehta G, Deelman E, et al. SPOT: a web-based tool for using biological databases to prioritize SNPs after a genome-wide association study. Nucleic Acids Res. 2010;38(Web Server issue):W201\u20139.","journal-title":"Nucleic Acids Res"},{"key":"56_CR12","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"FO Desmet","year":"2009","unstructured":"Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67.","journal-title":"Nucleic Acids Res"},{"key":"56_CR13","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1093\/bioinformatics\/btv470","volume":"31","author":"SG Coetzee","year":"2015","unstructured":"Coetzee SG, Coetzee GA, Hazelett DJ. motifbreakR: an R\/Bioconductor package for predicting variant effects at transcription factor binding sites. Bioinformatics. 2015;31:3847\u20139.","journal-title":"Bioinformatics"},{"key":"56_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"56_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1056\/NEJMra0905980","volume":"363","author":"TA Manolio","year":"2010","unstructured":"Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med. 2010;363:166\u201376.","journal-title":"N Engl J Med"},{"key":"56_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/bcp.12166","volume":"76","author":"JN Patel","year":"2013","unstructured":"Patel JN, McLeod HL, Innocenti F. Implications of genome-wide association studies in cancer therapeutics. Br J Clin Pharmacol. 2013;76:370\u201380.","journal-title":"Br J Clin Pharmacol"},{"key":"56_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrg3523","volume":"14","author":"TA Manolio","year":"2013","unstructured":"Manolio TA. Bringing genome-wide association findings into clinical use. Nat Rev Genet. 2013;14:549\u201358.","journal-title":"Nat Rev Genet"},{"key":"56_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5682","volume":"5","author":"K Chen","year":"2014","unstructured":"Chen K, Ma H, Li L, Zang R, Wang C, Song F, et al. Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women. Nat Commun. 2014;5:4682.","journal-title":"Nat Commun"},{"key":"56_CR19","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.1158\/1078-0432.CCR-11-0724","volume":"17","author":"RS Huang","year":"2011","unstructured":"Huang RS, Johnatty SE, Gamazon ER, Im HK, Ziliak D, Duan S, et al. Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients. Clin Cancer Res. 2011;17:5490\u2013500.","journal-title":"Clin Cancer Res"},{"key":"56_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1017\/thg.2012.38","volume":"15","author":"Y Lu","year":"2012","unstructured":"Lu Y, Chen X, Beesley J, Johnatty SE, Defazio A, Lambrechts S, et al. Genome-wide association study for ovarian cancer susceptibility using pooled DNA. Twin Res Human Genet. 2012;15:615\u201323.","journal-title":"Twin Res Human Genet"},{"key":"56_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00439-013-1383-3","volume":"133","author":"MA Earp","year":"2014","unstructured":"Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, et al. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet. 2014;133:481\u201397.","journal-title":"Hum Genet"},{"key":"56_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12253-014-9822-6","volume":"21","author":"A Mostowska","year":"2015","unstructured":"Mostowska A, Sajdak S, Pawlik P, Markowska J, Pawalowska M, Lianeri M, et al. Replication study for the association of seven genome- GWAS-identified loci with susceptibility to ovarian cancer in the Polish population. Pathol Oncol Res. 2015;21:307\u201313.","journal-title":"Pathol Oncol Res"},{"key":"56_CR23","doi-asserted-by":"publisher","first-page":"9562","DOI":"10.1073\/pnas.94.18.9562","volume":"94","author":"D Zhang","year":"1997","unstructured":"Zhang D, Sliwkowski MX, Mark M, Frantz G, Akita R, Sun Y, et al. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci USA. 1997;94:9562\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"56_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0014-4827(02)00102-7","volume":"284","author":"DL Falls","year":"2003","unstructured":"Falls DL. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res. 2003;284:14\u201330.","journal-title":"Exp Cell Res"},{"key":"56_CR25","first-page":"247","volume":"107","author":"NJ Maihle","year":"2002","unstructured":"Maihle NJ, Baron AT, Barrette BA, Boardman CH, Christensen TA, Cora EM, et al. EGF\/ErbB receptor family in ovarian cancer. Cancer Treat Res. 2002;107:247\u201358.","journal-title":"Cancer Treat Res"},{"key":"56_CR26","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/bjc.2011.62","volume":"104","author":"Q Sheng","year":"2011","unstructured":"Sheng Q, Liu J. The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer. Br J Cancer. 2011;104:1241\u20135.","journal-title":"Br J Cancer"},{"key":"56_CR27","unstructured":"National Center for Biotechnology Information. Gene. Available from: https:\/\/www.ncbi.nlm.nih.gov\/gene\/?term= [Accessed Feb 2018]."},{"key":"56_CR28","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1002\/ijc.30603","volume":"140","author":"M Fane","year":"2017","unstructured":"Fane M, Harris L, Smith AG, Piper M. Nuclear factor one transcription factors as epigenetic regulators in cancer. Int J Cancer. 2017;140:2634\u201341.","journal-title":"Int J Cancer"},{"key":"56_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13072-015-0050-4","volume":"8","author":"YG Tak","year":"2015","unstructured":"Tak YG, Farnham PJ. Making sense of GWAS: using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome. Epigenetics Chromatin. 2015;8:57.","journal-title":"Epigenetics Chromatin"},{"key":"56_CR30","doi-asserted-by":"publisher","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","volume":"309","author":"TL Yeung","year":"2015","unstructured":"Yeung TL, Leung CS, Yip KP, Au Yeung CL, Wong ST, Mok SC. Cellular and molecular processes in ovarian cancer metastasis. A review in the theme: cell and molecular processes in cancer metastasis. Am J Physiol Cell Physiol. 2015;309:C444\u201356.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"Suppl 1","key":"56_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1525-1438.2006.00321.x","volume":"16","author":"F Smet De","year":"2006","unstructured":"De Smet F, Pochet NL, Engelen K, Van Gorp T, Van Hummelen P, Marchal K, et al. Predicting the clinical behavior of ovarian cancer from gene expression profiles. Int J Gynecol Cancer. 2006;16(Suppl 1):147\u201351.","journal-title":"Int J Gynecol Cancer"},{"key":"56_CR32","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1007\/s00018-007-7120-0","volume":"64","author":"M Breuleux","year":"2007","unstructured":"Breuleux M. Role of heregulin in human cancer. Cell Mol life Sci. 2007;64:2358\u201377.","journal-title":"Cell Mol life Sci"},{"key":"56_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","volume":"26","author":"S Pradeep","year":"2014","unstructured":"Pradeep S, Kim SW, Wu SY, Nishimura M, Chaluvally-Raghavan P, Miyake T, et al. Hematogenous metastasis of ovarian cancer: rethinking mode of spread. Cancer Cell. 2014;26:77\u201391.","journal-title":"Cancer Cell"},{"key":"56_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fgene.2016.00037","volume":"7","author":"BL Fridley","year":"2016","unstructured":"Fridley BL, Ghosh TM, Wang A, Raghavan R, Dai J, Goode EL, et al. Genome-wide study of response to platinum, taxane, and combination therapy in ovarian cancer: in vitro phenotypes, inherited variation, and disease recurrence. Front Genet. 2016;7:37.","journal-title":"Front Genet"},{"key":"56_CR35","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.1158\/0008-5472.CAN-11-0773","volume":"71","author":"TR Rebbeck","year":"2011","unstructured":"Rebbeck TR, Mitra N, Domchek SM, Wan F, Friebel TM, Tran TV, et al. Modification of BRCA1-associated breast and ovarian cancer risk by BRCA1-interacting genes. Cancer Res. 2011;71:5792\u2013805.","journal-title":"Cancer Res"},{"key":"56_CR36","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.febslet.2015.01.026","volume":"589","author":"DV Ho","year":"2015","unstructured":"Ho DV, Chan JY. Induction of Herpud1 expression by ER stress is regulated by Nrf1. FEBS Lett. 2015;589:615\u201320.","journal-title":"FEBS Lett"},{"issue":"Pt 15","key":"56_CR37","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1242\/jcs.001222","volume":"120","author":"H Huang","year":"2007","unstructured":"Huang H, Tindall DJ. Dynamic FoxO transcription factors. J Cell Sci. 2007;120(Pt 15):2479\u201387.","journal-title":"J Cell Sci"},{"key":"56_CR38","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/sj.bjc.6604279","volume":"98","author":"T Goto","year":"2008","unstructured":"Goto T, Takano M, Hirata J, Tsuda H. The involvement of FOXO1 in cytotoxic stress and drug-resistance induced by paclitaxel in ovarian cancers. Br J Cancer. 2008;98:1068\u201375.","journal-title":"Br J Cancer"},{"key":"56_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep23506","volume":"6","author":"W Shi","year":"2016","unstructured":"Shi W, Tang MK, Yao Y, Tang C, Chui YL, Lee KK. BRE plays an essential role in preventing replicative and DNA damage-induced premature senescence. Sci Rep. 2016;6:23506.","journal-title":"Sci Rep"},{"key":"56_CR40","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/1759-7714.12313","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Qi K, Zu L, Wang M, Wang Y, Zhou Q. Anti-apoptotic brain and reproductive organ-expressed proteins enhance cisplatin resistance in lung cancer cells via the protein kinase B signaling pathway. Thorac Cancer. 2016;7:190\u20138.","journal-title":"Thorac Cancer"},{"key":"56_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.bbrc.2004.11.013","volume":"326","author":"BC Chan","year":"2005","unstructured":"Chan BC, Li Q, Chow SK, Ching AK, Liew CT, Lim PL, et al. BRE enhances in vivo growth of tumor cells. Biochem Biophys Res Commun. 2005;326:268\u201373.","journal-title":"Biochem Biophys Res Commun"},{"key":"56_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/bib\/bbq074","volume":"12","author":"IR Konig","year":"2011","unstructured":"Konig IR. Validation in genetic association studies. Brief Bioinform. 2011;12:253\u20138.","journal-title":"Brief Bioinform"},{"key":"56_CR43","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrg2344","volume":"9","author":"MI McCarthy","year":"2008","unstructured":"McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008;9:356\u201369.","journal-title":"Nat Rev Genet"},{"key":"56_CR44","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ng.840","volume":"43","author":"ML Freedman","year":"2011","unstructured":"Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet. 2011;43:513\u20138.","journal-title":"Nat Genet"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41397-018-0056-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41397-018-0056-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41397-018-0056-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T16:09:40Z","timestamp":1693930180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-018-0056-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["56"],"URL":"https:\/\/doi.org\/10.1038\/s41397-018-0056-y","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]},"assertion":[{"value":"13 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}